Clinical Trials Directory

Trials / Completed

CompletedNCT02708485

Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease

Evaluating the Impact of Physical Exercise on Mild Alzheimer's Disease in a Randomized Clinical Trial: Quantification With 18F -FDG and 11C- AcAc PET Imaging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effect of a 3-month walking program on brain energy metabolism in patient with mild Alzheimer's disease (AD). Two groups of sedentary patients with mild AD are followed and compared over a 3-month period of time: Control (non-active) and walking (from 15 to 45 minutes of exercise on a treadmill, 3 times a week for 12 weeks) groups. All the participants are evaluated on their cognition, brain volumes (MRI) and brain fuel consumption (PET scan with 18-FDG and 11C-AcAc) at the beginning and at the end of the study.

Conditions

Interventions

TypeNameDescription
OTHERPhysical exerciseA 3-month walking program (3 times a week for 12 weeks) on treadmill supervised by a physiotherapist. Duration of the exercise is progressively increased from 15 min to 45 min over a 6-week period and the intensity of the exercise is moderate (a 12-13 score on Borg scale).

Timeline

Start date
2009-04-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-03-15
Last updated
2018-10-16
Results posted
2018-10-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02708485. Inclusion in this directory is not an endorsement.